Share on Facebook
Share on Twitter
Share on LinkedIn

HCA Holdings Inc. (HCA), which operates 280 hospitals and surgery centers in the U.S. and England, will stop the use of a minimally invasive surgical device that destroys growths in a woman’s uterus after U.S. regulators said it may spread cancer.

HCA implemented the ban after the Food and Drug Administration on Nov. 24 updated its guidance on the devices, called power morcellators, Jeff Prescott, a spokesman for the Nashville, Tennessee-based company said yesterday in an e-mail.

Click here to read more.